These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 29414300)
1. Letter to the Editors - Multiple sclerosis and related disorders - Birnbaum et al., 2017. Tourbah A; Sedel F Mult Scler Relat Disord; 2018 Feb; 20():204. PubMed ID: 29414300 [No Abstract] [Full Text] [Related]
2. Response to: S. Sega-Jazbec et al.: "Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis" Multiple Sclerosis and Related Disorders 2017. Thomas K; Ziemssen T Mult Scler Relat Disord; 2017 Oct; 17():177-178. PubMed ID: 29055453 [No Abstract] [Full Text] [Related]
3. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al]. Hohlfeld R; Engelhardt D Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771 [No Abstract] [Full Text] [Related]
4. Letter to the editor regarding Gholamzad et al., "A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future". Faissner S Inflamm Res; 2020 Feb; 69(2):153. PubMed ID: 31927617 [No Abstract] [Full Text] [Related]
5. Letter: Bitemporal visual field loss in presumed multiple sclerosis. Lavenstein B JAMA; 1976 Feb; 235(8):804. PubMed ID: 946304 [No Abstract] [Full Text] [Related]
7. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814 [TBL] [Abstract][Full Text] [Related]
8. [Haptoglobin levels in the serum and the cerebrospinal fluid patients with multiple sclerosis]. Rosnowska M; Cendrowski W Neurol Neurochir Pol; 1978; 12(5):579-85. PubMed ID: 724031 [TBL] [Abstract][Full Text] [Related]